EnPlusOne Biosciences

EnPlusOne Biosciences

  • Founded: 2022
  • Location: Watertown, MA
  • Employee range: 1 - 10
  • Funding: $12M Seed Sep 2022
  • Investors: Northpond Ventures, Breakout Ventures, Coatue



job board

Short description:

Enzymatic RNA Synthesis Platform

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

EnPlusOne Biosciences is harnessing the power and flexibility of enzymes to develop RNA therapeutics. There is currently a lot of interest in creating RNA therapeutics but a lack of companies that can generate the diverse forms of RNA efficiently. Using their proprietary ezRNATM platform, EnPlusOne is building RNA enzymatically to promise long-term manufacturing solutions to sustainably deliver RNA therapeutics at scale. These abilities range from de novo RNA synthesis to single RNA extensions off of therapeutic payloads, as well as incorporating a diverse array of nucleotide modifications, all using aqueous-based reaction conditions.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com